Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This is a Phase I label dose escalation study of KW-0761 in relapsed patients with CCR4
positive Adult T-Cell Leukemia-Lymphoma (ATL) and Peripheral T-Cell lymphoma (PTCL).
Phase:
Phase 1
Details
Lead Sponsor:
Kyowa Hakko Kirin Company, Limited Kyowa Kirin Co., Ltd.